Document Detail

Palliative Treatment of Metastatic Colorectal Cancer: What is the Optimal Approach?
MedLine Citation:
PMID:  24293074     Owner:  NLM     Status:  In-Data-Review    
Worldwide, colorectal cancer (CRC) is responsible for over 600,000 deaths annually and remains a significant public health concern. Because of therapeutic advancements over the past two decades, patients with metastatic CRC are living longer with an improved quality of life. This review will highlight recent trial evidence that improves outcomes for patients with metastatic disease. Topics will include the optimal use of first-line combination chemotherapy, bevacizumab in patients with advanced age or comorbidities, maintenance chemotherapy, first-line use of anti-EGFR therapies, first-line cetuximab versus bevacizumab, anti-angiogenic therapies past progression, and management of treatment-refractory disease. Clinical trial evidence will be presented, along with guidance on how to integrate recent evidence into clinical practice. Finally, this review will examine innovative drug development strategies, and will discuss potentially actionable targets identified by molecular testing.
John H Strickler; Herbert I Hurwitz
Related Documents :
20922524 - Long-term follow-up of patients with chronic myeloid leukemia having received autologou...
16363884 - Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and co...
23536054 - Association of positive transection margins with gastric cancer survival and local recu...
16902984 - Hodgkin transformation of chronic lymphocytic leukemia: the m. d. anderson cancer cente...
2767094 - Management of patients with localized prostatic carcinoma.
18324444 - Tumor-positive sentinel node biopsy of the groin in clinically node-negative melanoma p...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current oncology reports     Volume:  16     ISSN:  1534-6269     ISO Abbreviation:  Curr Oncol Rep     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2013-12-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888967     Medline TA:  Curr Oncol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  363     Citation Subset:  IM    
Department of Medicine, Division of Medical Oncology, Duke University Medical Center, DUMC 2823, Durham, NC, 27710, USA,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin...
Next Document:  African American and Latino Low Income Families' Food Shopping Behaviors: Promoting Fruit and Vegeta...